Randomized Controlled Clinical Trial to Evaluate the Efficacy of Amrutadi Yog in Essential Hypertension

未提供2 个研究点分布在 1 个国家目标入组 220 人开始时间: 2019年1月7日最近更新: 2022年11月21日

试验速览

阶段: 3 期
状态: 招募中
入组人数: 220
试验地点: 2
主要终点: reduction in blood pressure

研究概览研究设计入排标准结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

This study is randomised controlled trial to evaluate the efficasy of ayurvedic formulation amrutadi yog which contains Amruta Tinospora cordifolia Willd. Miers.exHK.F.and Th., Gokshur Tribulus terrestris Linn, Jatamansi Nordostachys jatamansi (D.Don) DC. Parsik Yavani, Hysocymus niger Linn. Amalaki Phyllanthus emblica Linn Haritaki Terminalia chebula Retz. Trial drug dose 1 gm bid and control drug dose 20 mg once in day in the morning for 8 weeks for 110 patients in each group. study will be conducted in India. outcome of study will be asses on reduction of blood pressure and sign symptoms of hypertension.

研究设计

研究类型: Interventional
分配方式: Computer generated randomization
盲法: Open Label

入排标准

年龄范围: 18.00 Year(s) 至 60.00 Year(s)（—）
性别: All

入选标准

•Newly diagnosed patients of stage 1 essential hypertension with blood pressure systolic blood pressure is equal to and more than 140 mmHg and less than 160 mmHg and diastolic blood pressure is equal to and more than 90 mmHg and less than 100 mmHg.

排除标准

•1.Patients receiving anti-hypertensive drug.
•2.Complicated hypertensive cases.
•Known case of Nephropathy, Left Ventricular Hypertrophy, heart block, Congestive Cardiac Failure, Coronary Artery Disease and retinopathy.
•Patients suffering from Diabetes Mellitus and severe other illness like hepatic or renal failure.
•3.Secondary, Accelerated and Malignant Hypertension 4.Patients taking steroids, oral contraceptive pills, estrogen replacement therapy or NSAIDS group of drug 5.Pregnant women or planning pregnancy within six months.

结局指标

主要结局

reduction in blood pressure

时间窗: 8 weeks

次要结局

sign and symptoms of hypertension rlief(8 weeks)

研究者

发起方

未提供

研究点 (2)

Loading locations...

相似试验

尚未招募

2 期

To study the effect of amrutadi churn in the management of amavata

CTRI/2021/11/037759HonShri Annasaheb Dange ayurved medical college and PG research center Ashta TalWalwa Distsangli

已完成

不适用

Ayurvedic Nutritional Counseling for Patients With IBS in Comparison to Conventional Nutritional CounselingIBS - Irritable Bowel Syndrome

NCT03019861Charite University, Berlin, Germany69

已完成

2 期

Study of Herbmed Plus in Ureteral Stent DiscomfortUreteral Stent Discomfort

NCT01356355Dr .S.B.PATANKAR140

尚未招募

1 期

Efficacy of Ayurveda treatment Protocol with Tulsimmune Tablet in Covid 19

CTRI/2020/07/026675Suraj Ayurveda Clinic and Research center

尚未招募

2 期

se of ayurvedic drug in the management of urinary infection.

CTRI/2023/08/056345Keshav ayurvedic medical college and hospital